Showing results (1231-1240 of 3,081) with videos related to

Sort By:
Pageof 309
Drug Safety|November 4, 2019
Development and First Use of the Patient's Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit-Harm of Drugs Received During Clinical StudiesAdam Gater, Matthew Reaney, Amy Findley, et al.
Drug Safety|January 8, 2020
Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity MonitoringHani Shamseddeen, Eduardo Vilar-Gomez, Naga Chalasani, et al.
Drug Safety|January 10, 2020
Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical RecordAmoah Yeboah-Korang, Jeremy Louissaint, Irene Tsung, et al.
Drug Safety|January 10, 2020
Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a QuestionnaireNanno Schreuder, Quincy de Hoog, Sieta T de Vries, et al.
Drug Safety|February 7, 2019
Correction to: Implications of Individual QT/RR Profiles-Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc ChangesMarek Malik, Christine Garnett, Katerina Hnatkova, et al.
Drug Safety|February 11, 2019
Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development ProgramsSubrata Ghosh, Lianne S Gensler, Zijiang Yang, et al.
Drug Safety|January 25, 2020
Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance DatabaseThomas Berbain, Antoine Pariente, Ghada Miremont-Salamé, et al.
Drug Safety|January 26, 2020
An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting SystemKathryn Marwitz, S Christopher Jones, Cindy M Kortepeter, et al.
Drug Safety|March 27, 2020
Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The NetherlandsEsther de Vries, Petra Denig, Sieta T de Vries, et al.
Drug Safety|August 28, 2020
Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic OriginsVictoria Rollason, Médéric Mouterde, Youssef Daali, et al.
Pageof 309